Annals of the rheumatic diseases
-
Randomized Controlled Trial Multicenter Study
Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
To determine the safety profile of anakinra after extended exposure in a diverse clinical trial population of patients with rheumatoid arthritis. ⋯ Anakinra is safe and well tolerated for up to three years of continuous use in a diverse population of patients with rheumatoid arthritis.